摘要
目的:寻找克服肿瘤细胞多药耐药的方法。方法:以FAT作为耐药逆转剂,采用流式细胞术,观察FAT对K562和K562/A02内药物的积聚和外排的影响。结果:FAT可增加K562/A02细胞内罗丹明123(Rhodamine 123)的含量,且存在剂量依赖关系,而对于K562细胞无明显影响。结论:FAT有望成为一种新型多药耐药逆转剂。
Objective:To explore measures to overcome multidrug resistance of tumor ceils. Methods:The effect of FAT on intracellular drug accumulation and drug efflux in K562 cell line and K562/A02 cell line was studied by flow cytometry. Results:FAT increased the intracellular Rho-123 concentration,the role of drug resistance reversal was FAT dose-dependant. The content of Rho- 123 was not influenced by FAT in K562 cell line nearly. Conclusion:FAT is a novel multidrug resistance reversal agents.
出处
《亚太传统医药》
2012年第1期9-10,共2页
Asia-Pacific Traditional Medicine
关键词
白血病
FAT
多药耐药逆转
Leukemia
FAT
Reversal of Multidrug Resistance